A phase 2 study of single agent ibrutinib for first-line treatment of chronic graft-versus-host disease: A new paradigm and lessons learned

Najla El Jurdi, Noa G. Holtzman, Rania Hishmeh, Alain Mina, Eduard Schulz, Anita Stokes, Grace Li, Keith T. Schmidt, William D. Figg, Nicholas Micheletti, Jacqueline W. Mays, Edward W. Cowen, Steven Z. Pavletic, Iskra Pusic

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1822-1827
Number of pages6
JournalBritish Journal of Haematology
Volume206
Issue number6
DOIs
StatePublished - Jun 2025

Keywords

  • allogeneic haematopoietic cell transplantation
  • chronic graft-versus-host disease
  • front-line treatment
  • ibrutinib

Cite this